O’Neil Health Care Weekly

XLV retraced last week’s gains, reversing from 50-DMA ($133.67) resistance to close 3.1% lower and below its 10- and
21-DMA. All three moving averages will now act as near-term resistance. The next level of support is $125.28 before
~$124.

Market View

The U.S. market remains in a Confirmed Uptrend. The S&P 500 and Nasdaq held slightly above 21-DMA support
(S&P 500: 4,086; Nasdaq: 11,981) this week, consolidating sharp gains off recent lows in choppy fashion. The next level
of logical resistance for both indices is the sharply falling 50-DMA (S&P 500: 4,249; Nasdaq: 12,773). Following Tuesday’s
rebalancing volume spike, volume came in well below average for the remaining three sessions allowing the distribution
day count to stay at one each.

O’Neil Health Care Weekly

XLV gained 3.3% last week, sharply underperforming 6%+ gains for the broader indices. Despite the lag, its RS line is still
trending upwards. The ETF now faces resistance directly at its 50-DMA ($134.08). Should it clear above this level, the
next level of resistance is 138.42. Support is now the curling 10- and 21-DMA ($131.05).

Market View

The U.S. market is in a Confirmed Uptrend. The Nasdaq staged a day five follow-through on Thursday, gaining 2.7% in
higher day/day volume. The index regained both its 10-DMA (11,687) and 21-DMA (11,925) which will now act as nearterm downside support. The rolling 50-DMA (12,920) is now the next level of logical resistance. The S&P 500 rallied in
lower volume, but also regained its 10-DMA (4,024) and 21-DMA (4,066), with the 50-DMA (4,277) now also the next level
of resistance.

Eight of 11 sectors gained 5% or more this week, led by Energy, Retail and Consumer Cyclical, which gained 7-8%.
Energy continues to push further into highs and is now trading ~30% above its 200-DMA which is the biggest extension
since June 2021. Technology gained ~6%, clearing above its 10- and 21-DMA with the 50-DMA now trading ~6% above
current levels. Energy and Utility are still the only sectors trading above both the 50- and 200-DMA. The best performing
industry groups this week included Consumer Electronics, Department Stores, Discount Retail, Specialty Retail, Lodging,
Oil & Gas, Solar, Semiconductors and Banks. The worst performing groups included TV Media, Biotech, Pharma,
Outpatient Care, Generic Drugs, Agriculture, Mining, Staffing, Water Utilities, and Internet.

Market View

The U.S. market is in a Confirmed Uptrend. The Nasdaq staged a day five follow-through on Thursday, gaining 2.7% in
higher day/day volume. The index regained both its 10-DMA (11,687) and 21-DMA (11,925) which will now act as nearterm downside support. The rolling 50-DMA (12,920) is now the next level of logical resistance. The S&P 500 rallied in
lower volume, but also regained its 10-DMA (4,024) and 21-DMA (4,066), with the 50-DMA (4,277) now also the next level
of resistance.

Market View

The U.S. market is in a Downtrend. The S&P 500 and Nasdaq staged a follow-through day (FTD) Tuesday, before
quickly failing on Friday by undercutting year-to-date lows. This is now the third failed FTD this year. Since 1971, there
have been 33 S&P 500 corrections (9% off highs and below 200-DMA) of which seven turned into bear markets. These
seven bear markets had a median of six failed FTDs. Support is now ~3,700 on the S&P 500 and ~10,500 on the
Nasdaq. Near-term resistance remains the declining 10-DMA (S&P 500: 3,985, Nasdaq: 11,670).

Market View

The U.S. market is in a Downtrend. The S&P 500 and Nasdaq declined 2.4% and 2.8%, respectively, each falling for a
sixth straight week. Despite another steep weekly decline, both indices are now two days off recent lows (S&P 500:
3,858; Nasdaq: 11,108) and set to again face resistance at the sharply falling 10-DMA (S&P 500: 4,063; Nasdaq: 11,965)
and 21-DMA (S&P 500: 4,167; Nasdaq: 12,430).

O’Neil Health Care Weekly

XLV reversed from 200-DMA ($133) resistance, closing down for a fourth straight week. Despite another pullback, the
ETF’s RS line is making highs, outperforming the broader market. There is still support between ~$127.50 to $129, before year-to-date lows of $124.06.